TY - JOUR
T1 - Tumor-educated platelets
AU - in 't Veld, Sjors G. J. G.
AU - Wurdinger, Thomas
PY - 2019/5/30
Y1 - 2019/5/30
N2 - Liquid biopsies have been considered the holy grail in achieving effective cancer management, with blood tests offering a minimally invasive, safe, and sensitive alternative or complementary approach for tissue biopsies. Currently, blood-based liquid biopsy measurements focus on the evaluation of biomarker types, including circulating tumor DNA, circulating tumor cells, extracellular vesicles (exosomes and oncosomes), and tumor-educated platelets (TEPs). Despite the potential of individual techniques, each has its own advantages and disadvantages. Here, we provide further insight into TEPs.
AB - Liquid biopsies have been considered the holy grail in achieving effective cancer management, with blood tests offering a minimally invasive, safe, and sensitive alternative or complementary approach for tissue biopsies. Currently, blood-based liquid biopsy measurements focus on the evaluation of biomarker types, including circulating tumor DNA, circulating tumor cells, extracellular vesicles (exosomes and oncosomes), and tumor-educated platelets (TEPs). Despite the potential of individual techniques, each has its own advantages and disadvantages. Here, we provide further insight into TEPs.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065416495&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/30833413
U2 - https://doi.org/10.1182/blood-2018-12-852830
DO - https://doi.org/10.1182/blood-2018-12-852830
M3 - Article
C2 - 30833413
SN - 0006-4971
VL - 133
SP - 2359
EP - 2364
JO - Blood
JF - Blood
IS - 22
ER -